Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University Hospital, Basel, Switzerland
With
Swiss Multiple Sclerosis Society
Bangerter-Rhyner Stiftung
Center for Chronic Immunodeficiency (CCI) in Freiburg, Germany
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Signed informed consent form (ICF) for the InRIMS-study and Swiss MS Cohort (SMSC) and/or Serially Unified Multicenter Multiple Sclerosis Investigation (SUMMIT) study
You may not be if
Not able to sufficiently understand the patient information and questionnaire (German language)
MS Patients with long-term antibiotic prophylaxis
MS Patients with known primary immunodeficiency, under chemotherapy due to any malignancy or HIV infection.
Clareo Health | Prospective Stratification of Infectious Risks in Multiple Sclerosis
